VHCP Management II

Latest statistics and disclosures from VHCP Management II's latest quarterly 13F-HR filing:

VHCP Management II portfolio companies for March 2017 quarter

Company (Ticker) Portfolio Weight Share Count Price Last Trade
Avexis 32.22 1.04M 76.03 0.00
BioCryst Pharmaceuticals (BCRX) 20.86 6.07M 8.40 6.12
Ascendis Pharma A S 9.30 811492 +12.00% 28.00 0.00
Dbv Technologies 7.64 373617 50.01 0.00
Edge Therapeutics 7.21 1.93M 9.11 0.00
Ra Pharmaceuticals 6.32 725029 +33.00% 21.29 0.00
Audentes Therapeutics Inc Com stock 3.20 458882 17.04 0.00
Axovant Sciences 2.63 429590 14.94 0.00
Cytomx Therapeutics 2.04 288915 -50.00% 17.27 0.00
Acceleron Pharma 1.70 156880 NEW 26.47 0.00
Akari Therapeutics 1.67 369490 11.07 0.00
ARCA biopharma (ABIO) 1.13 1.08M 2.55 2.35
Coherus Biosciences 0.82 95276 -26.00% 21.15 0.00
D Stemline Therapeutics 0.80 228130 -27.00% 8.55 0.00
Lipocine 0.67 420000 3.90 0.00
Kalvista Pharmaceuticals 0.67 221651 7.38 0.00
Ocera Therapeutics 0.65 1.22M 1.31 0.00
Adverum Biotechnologies 0.31 280000 2.70 0.00
Alcobra 0.09 185140 -87.00% 1.14 0.00
Sierra Oncology 0.08 130798 NEW 1.53 0.00

Past 13F-HR SEC Filings for VHCP Management II